Banco Santander S.A. Has $26.50 Million Holdings in UnitedHealth Group Incorporated $UNH

Banco Santander S.A. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 63.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,937 shares of the healthcare conglomerate’s stock after buying an additional 32,981 shares during the period. Banco Santander S.A.’s holdings in UnitedHealth Group were worth $26,498,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. OVERSEA CHINESE BANKING Corp Ltd boosted its position in UnitedHealth Group by 15.3% in the second quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 52,573 shares of the healthcare conglomerate’s stock valued at $16,374,000 after buying an additional 6,969 shares in the last quarter. Delta Investment Management LLC lifted its position in shares of UnitedHealth Group by 298.1% during the second quarter. Delta Investment Management LLC now owns 27,002 shares of the healthcare conglomerate’s stock worth $8,424,000 after purchasing an additional 20,220 shares in the last quarter. New Hampshire Trust lifted its position in shares of UnitedHealth Group by 14.1% during the second quarter. New Hampshire Trust now owns 937 shares of the healthcare conglomerate’s stock worth $292,000 after purchasing an additional 116 shares in the last quarter. Prudent Man Advisors LLC lifted its position in shares of UnitedHealth Group by 34.2% during the second quarter. Prudent Man Advisors LLC now owns 3,659 shares of the healthcare conglomerate’s stock worth $1,141,000 after purchasing an additional 932 shares in the last quarter. Finally, VestGen Investment Management lifted its position in shares of UnitedHealth Group by 17.0% during the second quarter. VestGen Investment Management now owns 723 shares of the healthcare conglomerate’s stock worth $226,000 after purchasing an additional 105 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Oppenheimer cut their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Robert W. Baird restated an “underperform” rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Stock Up 0.6%

Shares of UNH stock opened at $362.78 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm’s fifty day moving average price is $338.43 and its two-hundred day moving average price is $335.78. The firm has a market capitalization of $328.56 billion, a P/E ratio of 15.72, a PEG ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.